Europe Extracorporeal CO2 Removal Devices Market Size and Forecast (2021 - 2031)
The Europe Extracorporeal CO2 Removal Devices Market is projected to grow significantly, reaching an estimated US$ 48.4 million by 2031, up from US$ 30.6 million in 2024, reflecting a compound annual growth rate (CAGR) of 6.9% from 2025 to 2031. This growth is primarily driven by the region's advanced healthcare infrastructure, a high prevalence of respiratory diseases, and a strong emphasis on innovative medical technologies.
The market is segmented into key countries including Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe holds a crucial position in the Extracorporeal CO2 Removal (ECCO2R) devices market, largely due to its mature healthcare systems, particularly in Germany, France, the UK, and the Nordic countries. These systems have facilitated the adoption of advanced extracorporeal therapies for managing complex respiratory conditions such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). The focus on improving patient outcomes and reducing hospital stays has led to increased investments in efficient and minimally invasive extracorporeal support systems.
The regulatory landscape in Europe, governed by stringent frameworks from agencies like the European Medicines Agency (EMA), ensures that only high-quality and safe devices are introduced into the market, thereby enhancing trust among healthcare providers. The presence of major market players, many of whom are based in Europe, fosters continuous innovation and product development tailored to meet regional clinical needs. Additionally, rising awareness of the benefits of ECCO2R devices in treating respiratory failure, along with increased research initiatives and clinical trials across Europe, supports market growth. The aging population in Europe, which is more susceptible to chronic respiratory diseases, further drives the demand for advanced extracorporeal therapies.
Despite the promising growth, challenges such as the high costs of devices and procedures, along with the need for specialized training and infrastructure, may hinder widespread adoption in certain areas. Nevertheless, the European market remains robust, with a clear trajectory towards integrating ECCO2R devices into standard respiratory care protocols. Collaborative efforts among healthcare providers, regulatory bodies, and industry players are expected to propel growth and technological advancements in the coming years, positioning Europe as a pivotal region in the global ECCO2R devices landscape.
Market Segmentation Analysis
The Europe Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user. By product, the market is divided into Extracorporeal CO2 Devices and Consumables, with the Extracorporeal CO2 Devices segment leading the market in 2024. In terms of application, the market is categorized into Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and others, with COPD being the dominant segment. For end users, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and others, where Hospitals and Clinics held the largest share in 2024.
Market Outlook
The most significant opportunity for the ECCO2R devices market lies in the rapidly growing demand in developing countries, particularly in the Asia Pacific (APAC) region. This growth is driven by an aging population that is increasingly vulnerable to chronic respiratory diseases, coupled with rapid industrialization and urbanization leading to higher pollution levels. For instance, the prevalence of COPD in China has reached approximately 16.7% of the population, indicating a substantial need for advanced respiratory support like ECCO2R.
Healthcare infrastructure improvements and increased spending by both public and private sectors in the APAC and Latin America regions are facilitating the adoption of advanced healthcare devices. Governments in countries such as India and China are investing in enhancing critical care capacities, establishing more tertiary care centers where ECCO2R devices can be utilized. The COVID-19 pandemic has further underscored the limitations of standard ventilation strategies, highlighting the importance of extracorporeal support and driving awareness and deployment of these technologies.
Manufacturers are shifting their focus from high-end ECMO systems to more affordable and user-friendly ECCO2R systems tailored to the needs of emerging markets. Companies like Medtronic, Getinge, and Fresenius Medical Care are expanding their local presence and product offerings to meet the demands of these regions. New ECCO2R devices are being designed to be smaller, more portable, and easier to operate, making them suitable for environments where specialized personnel may not be available.
Country Insights
In terms of country-specific insights, the UK held the largest market share in 2024, driven by ongoing improvements in critical care and a focus on innovative respiratory therapies. The National Health Service (NHS) has broadly approved the use of extracorporeal techniques for severe respiratory failure, leading to increased adoption of ECCO2R devices. The UK government and healthcare providers are committed to integrating state-of-the-art medical devices into their systems, supported by investments in ICU capabilities.
Overall, the Europe Extracorporeal CO2 Removal Devices Market is poised for significant growth, driven by technological advancements, increasing prevalence of respiratory diseases, and a commitment to improving patient care.
The market is segmented into key countries including Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe holds a crucial position in the Extracorporeal CO2 Removal (ECCO2R) devices market, largely due to its mature healthcare systems, particularly in Germany, France, the UK, and the Nordic countries. These systems have facilitated the adoption of advanced extracorporeal therapies for managing complex respiratory conditions such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). The focus on improving patient outcomes and reducing hospital stays has led to increased investments in efficient and minimally invasive extracorporeal support systems.
The regulatory landscape in Europe, governed by stringent frameworks from agencies like the European Medicines Agency (EMA), ensures that only high-quality and safe devices are introduced into the market, thereby enhancing trust among healthcare providers. The presence of major market players, many of whom are based in Europe, fosters continuous innovation and product development tailored to meet regional clinical needs. Additionally, rising awareness of the benefits of ECCO2R devices in treating respiratory failure, along with increased research initiatives and clinical trials across Europe, supports market growth. The aging population in Europe, which is more susceptible to chronic respiratory diseases, further drives the demand for advanced extracorporeal therapies.
Despite the promising growth, challenges such as the high costs of devices and procedures, along with the need for specialized training and infrastructure, may hinder widespread adoption in certain areas. Nevertheless, the European market remains robust, with a clear trajectory towards integrating ECCO2R devices into standard respiratory care protocols. Collaborative efforts among healthcare providers, regulatory bodies, and industry players are expected to propel growth and technological advancements in the coming years, positioning Europe as a pivotal region in the global ECCO2R devices landscape.
Market Segmentation Analysis
The Europe Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user. By product, the market is divided into Extracorporeal CO2 Devices and Consumables, with the Extracorporeal CO2 Devices segment leading the market in 2024. In terms of application, the market is categorized into Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and others, with COPD being the dominant segment. For end users, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and others, where Hospitals and Clinics held the largest share in 2024.
Market Outlook
The most significant opportunity for the ECCO2R devices market lies in the rapidly growing demand in developing countries, particularly in the Asia Pacific (APAC) region. This growth is driven by an aging population that is increasingly vulnerable to chronic respiratory diseases, coupled with rapid industrialization and urbanization leading to higher pollution levels. For instance, the prevalence of COPD in China has reached approximately 16.7% of the population, indicating a substantial need for advanced respiratory support like ECCO2R.
Healthcare infrastructure improvements and increased spending by both public and private sectors in the APAC and Latin America regions are facilitating the adoption of advanced healthcare devices. Governments in countries such as India and China are investing in enhancing critical care capacities, establishing more tertiary care centers where ECCO2R devices can be utilized. The COVID-19 pandemic has further underscored the limitations of standard ventilation strategies, highlighting the importance of extracorporeal support and driving awareness and deployment of these technologies.
Manufacturers are shifting their focus from high-end ECMO systems to more affordable and user-friendly ECCO2R systems tailored to the needs of emerging markets. Companies like Medtronic, Getinge, and Fresenius Medical Care are expanding their local presence and product offerings to meet the demands of these regions. New ECCO2R devices are being designed to be smaller, more portable, and easier to operate, making them suitable for environments where specialized personnel may not be available.
Country Insights
In terms of country-specific insights, the UK held the largest market share in 2024, driven by ongoing improvements in critical care and a focus on innovative respiratory therapies. The National Health Service (NHS) has broadly approved the use of extracorporeal techniques for severe respiratory failure, leading to increased adoption of ECCO2R devices. The UK government and healthcare providers are committed to integrating state-of-the-art medical devices into their systems, supported by investments in ICU capabilities.
Overall, the Europe Extracorporeal CO2 Removal Devices Market is poised for significant growth, driven by technological advancements, increasing prevalence of respiratory diseases, and a commitment to improving patient care.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 France: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 France: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.5.6.6 Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.5.6.6.2 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.5.6.6.3 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.6.7.7 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.6.7.7.2 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.6.7.7.3 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 United Kingdom: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Germany: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 France: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 France: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Italy: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.5.6.6 Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.5.6.6.2 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.5.6.6.3 Spain: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
10.6.7.7 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by Product
10.6.7.7.2 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by Application
10.6.7.7.3 Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 21. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 22. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 24. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 25. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
Table 1. Europe Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 21. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 22. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 24. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 25. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Europe Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Europe Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Europe Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
Figure 1. Europe Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Europe Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Europe Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Europe Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. United Kingdom: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Germany: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. France: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Italy: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Spain: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of Europe: Europe Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
